M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
New research reveals druggable target arising from chromosomal rearrangement in aggressive leukaemia
Researchers at the University of Oxford have uncovered a potential new therapeutic target in a particularly aggressive and hard-to-treat form of leukaemia.
A potential treatment for blast phase myeloproliferative neoplasm (BP-MPN), one of the most aggressive forms of leukaemia, has been...
If you want to view the full text of this story, you must first purchase archive credits. Return to Archives
New Search